A citation-based method for searching scientific literature

Benjamin E Peterson, Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao, Ralph T Doyle, Craig Granowitz, C Michael Gibson, Duane Pinto, Robert P Giugliano, Matthew J Budoff, Jean-Claude Tardif, Subodh Verma, Christie M Ballantyne. Circulation 2021
Times Cited: 26



Brian Olshansky, Deepak L Bhatt, Michael Miller, Ph Gabriel Steg, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Ralph T Doyle, Rebecca A Juliano, Lixia Jiao, Craig Granowitz, Jean-Claude Tardif, Cyrus Mehta, Rajat Mukherjee, Christie M Ballantyne, Mina K Chung. Eur Heart J Cardiovasc Pharmacother 2021
Times Cited: 11




List of shared articles



Times cited

Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI.
Benjamin E Peterson, Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao, Ralph T Doyle,[...]. J Am Heart Assoc 2022
3

Benefits of icosapent ethyl for enhancing residual cardiovascular risk reduction: A review of key findings from REDUCE-IT.
Prakriti Gaba, Deepak L Bhatt, R Preston Mason, Michael Miller, Subodh Verma, Ph Gabriel Steg, William E Boden. J Clin Lipidol 2022
0

Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT.
Prakriti Gaba, Deepak L Bhatt, Robert P Giugliano, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao,[...]. J Am Coll Cardiol 2021
10

Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL.
Arjun Majithia, Deepak L Bhatt, Allon N Friedman, Michael Miller, Ph Gabriel Steg, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao,[...]. Circulation 2021
7

The role of eicosapentaenoic acid in reducing important cardiovascular events, including coronary revascularization.
Ram D Bhatt, Peter Libby, Subodh Verma, R Preston Mason, Deepak L Bhatt. Prog Cardiovasc Dis 2021
6

Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction.
Prakriti Gaba, Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao, Ralph T Doyle,[...]. J Am Coll Cardiol 2022
5

Icosapent ethyl for reduction of persistent cardiovascular risk: a critical review of major medical society guidelines and statements.
Michael Miller, Lale Tokgozoglu, Klaus G Parhofer, Yehuda Handelsman, Lawrence A Leiter, Ulf Landmesser, Eliot A Brinton, Alberico L Catapano. Expert Rev Cardiovasc Ther 2022
0

Omega-3 and cardiovascular prevention - Is this still a choice?
Massimiliano Ruscica, Cesare R Sirtori, Stefano Carugo, Philip C Calder, Alberto Corsini. Pharmacol Res 2022
0